MedRx Co. Ltd. announced consolidated earnings results for the full year ended December 31, 2017. For the period, the company reported net sales of JPY 198 million compared with JPY 22 million for the same period a year ago. Operating loss was JPY 983 million compared with JPY 1,342 million for the same period a year ago. Ordinary loss was JPY 988 million compared with JPY 1,301 million for the same period a year ago. Loss attributable to owners of the parent was JPY 884 million or JPY 103.16 per share compared with JPY 1,259 million or JPY 155.48 per share for the same period a year ago. Cash used in operating activities was JPY 854 million compared with JPY 1,215 million for the same period a year ago.

The company provided earnings guidance for the first half and full year of 2018. For the first half, the company expects to report operating loss of JPY 811 million, ordinary loss of JPY 809 million and net loss of JPY 793 million or JPY 89.21 per share.

For the full year, the company expects to report net sales of JPY 698 million, operating loss of JPY 1,120 million, ordinary loss of JPY 1,115 million and net loss of JPY 1,100 million or JPY 123.79 per share.